titre

For more than 20 years,
we have been developing new addiction strategies

Read more

A program supported and funded by
biocodex, bpi france, European Union,
key-obs and région centre

Read more

addiction: a socio-economic problem
that affects more than 35 million people worldwide

Read more

KT-100, our first product,
is a real chance for addiction treatment
(in phase ii clinical trial)

Read more

A socio economic problem


Addiction is a huge
problem we try to solve.
The market is more than 3 billion USD and involves more than 35M people worldwide

Read More

Innovation research and development


With 20 years of experience,
we have developed new strategies to solve addiction problems

Read More

An effective treatment


Today, there is no real
solution to addiction.
Our first product,
KT-110,is a true chance of treatment.

Read More

European funds


Exceptional participation from Europe to finance clinical trials

Read More

Our mission : overcome the global challenge of addiction (alcohol, tobacco, cocaine, opioids… )

Kinnov-Therapeutics founders have worked on deciphering the pharmacological and biochemical mechanisms of addiction for more than 20 years, resulting in the identification of a disruptive strategy to treat addicted people. Indeed, addiction (alcohol, tobacco, gambling...) is becoming a serious socio-economic problem and for the sole US market, treatment of these pathologies reached $3 billion in 2013. Nevertheless, to date, few therapeutic agents are available and efficient on these pathologies of addiction.

COMMENT PARTICIPER AU PROJET COCKTAIL